Antimicrobial chemotherapy / Peter Davey, Mark Wilcox, William Irving, Guy Thwaites.

Oxford : Oxford University Press, 2015.

x, 419 pages : black and white illustrations, charts ; 25 cm

Seventh edition.

Preceded by: Antimicrobial chemotherapy / Roger Finch [and others]. Sixth edition. 2012.

Includes bibliographical references and index.

Part 1. General properties of antimicrobial agents. 1. Mechanisms of action and resistance to modern antibacterial with a history of their development ; 2. Inhibitors of bacterial cell wall synthesis ; 3. Inhibitors of bacterial protein synthesis ; 4. Synthetic antibacterial agents and miscellaneous antibiotics ; 5. Antiviral agents ; 6. Antiretroviral agents ; 7. Drugs used in the treatment of viral hepatitis ; 8. Antifungal agents ; 9. Antiprotozoal and anthelminthic agents -- Part 2. Resistance to antimicrobial agents. 10. The problem of resistance ; 11. The genetics and mechanisms of acquired resistance -- Part 3. General principles of usage of antimicrobial agents. 12. Laboratory investigations and the treatment of infection ; 13. General principles of the treatment of infection ; 14. Pharmacokinetic and pharmacodynamics principles ; 15. Prescribing in special groups : effects of age, pregnancy, body weight, hepatic and renal impairment 16: Outpatient parenteral antimicrobial therapy ; 17. Adverse drug reactions and patient safety ; 18. Chemoprophylaxis and immunisation ; 19. Guidelines, formularies, and antimicrobial policies ; 20. Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences -- Part 4. Therapeutic use of antimicrobial agents. 21. Respiratory tract infections ; 22. Topical use of antimicrobial agents ; 23. Urinary tract infections ; 24. Sexually transmitted infections ; 25. Gastrointestinal infections ; 26. Serious bacterial bloodstream infections ; 27. Bone and joint infections ; 28. Infections of the central nervous system ; 29. Skin and soft tissue infections ; 30. Tuberculosis and other mycobacterial diseases ; 31. Infections in immunocompromised patients including HIV/AIDs ; 32. Viral infections ; 33. Management of HIV infection ; 34. Treatment of chronic viral hepatitis ; 35. Parasitic disease ; 36. The development and marketing of antimicrobial drugs.